Sources for this note
Scientific sources checked October 21, 2026. Earlier research and provider sources retain their dated histories below. Provider sources describe advertised offers; they do not independently establish quality of care.
- CoreAge Rx — official treatment pagesProvider offer
- CoreAge Rx — tirzepatide offerProvider offer
- CoreAge Rx Help Center — Pricing & PlansProvider billing terms
- SuperHealthy Rx — current GLP-1 offerProvider offer
- Likeness Rx — GLP-1 plans and billingProvider offer
- Ro Body — membership and medication costsProvider offer
- WeightWatchers — Med+ membership and medicationProvider offer
- LillyDirect — pharmacy access and independent care optionsManufacturer access program
- FDA — concerns with unapproved GLP-1 drugsRegulator guidance · Checked 2026-10-21
- FDA — compounding questions and answersRegulator guidance
- FDA — dosing errors with compounded injectable semaglutideSafety alert, July 2024
- NIDDK — prescription medications for overweight and obesityFederal patient education
- Choosing a Safe & Successful Weight-loss Program - NIDDKPrimary health resource; checked October 5, 2026
- Prescription Medications to Treat Overweight & Obesity - NIDDKPrimary health resource; checked October 5, 2026
- Frequently Asked Questions (FAQs) | Form HealthProvider public offer; checked October 5, 2026
- Calibrate Weight Loss Pricing: How Much Does Calibrate Cost? | CalibrateProvider public offer; checked October 5, 2026
- What Should I Ask My Doctor During a Checkup?Primary health resource; checked October 5, 2026
- Frequently Asked Questions | LifeMD®Provider public offer; checked October 5, 2026
- Medical Weight Loss Programs Available OnlineProvider public offer; checked October 5, 2026
- Drugs for Diabetes or Weight Loss: What To Know Before SurgeryPrimary health resource; checked October 5, 2026
- It can be a lifesaving tool, especially during an emergencyPrimary health resource; checked October 5, 2026
- What is the cost of medication? - Form Health Patient Support CenterProvider public offer; checked October 5, 2026
- Online weight loss medication with or without insuranceProvider public offer; checked October 5, 2026
- Weight Management Program Overview | LifeMD®Provider public offer; checked October 5, 2026
- Programs & Membership Plans | LifeMD®️Provider public offer; checked October 5, 2026
- Boston Medical Group: SlimFitRx programProvider public information; checked October 15, 2026
- Boston Medical Group: Current GLP-1 offerProvider public information; checked October 15, 2026
- Boston Medical Group: Returns and refundsProvider public information; checked October 15, 2026
- Boston Medical Group: Service FAQProvider public information; checked October 15, 2026
- Boston Medical Group: Telehealth-site termsProvider public information; checked October 15, 2026
- Lemonaid Health: Weight-loss plans and live FAQProvider public information; checked October 15, 2026
- Lemonaid Health: May 4 terms of useProvider public information; checked October 15, 2026
- Lemonaid Health: May 4 cancellation policyProvider public information; checked October 15, 2026
- Lemonaid Health: Linked refund policyProvider public information; checked October 15, 2026
- Lemonaid Health: Semaglutide and B12 productProvider public information; checked October 15, 2026
- Lemonaid Health: Compounded tirzepatideProvider public information; checked October 15, 2026
- Lemonaid Health: Tirzepatide microdose offerProvider public information; checked October 15, 2026
- Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.Indexed original research abstract · Checked 2026-10-21
- FDA approves treatment for serious liver disease known as MASHOfficial FDA page read through web tool; historical approval announcement, not complete current labeling · Checked 2026-10-21
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.Primary research or official information · Checked 2026-10-21
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.Primary research or official information · Checked 2026-10-21
- Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.Indexed original research abstract · Checked 2026-10-21
- Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity.Indexed original research abstract · Checked 2026-10-21
- DailyMed - FOUNDAYO- orforglipron tablet, film coatedOfficial page retrieved in full · Checked 2026-10-21
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.Primary research or official information · Checked 2026-10-21